Month: February 2022
-
Trial Assessing AI-Aided Blood Test for Early Stage Cancer
A clinical trial is underway enrolling people with and without cancer to evaluate blood samples analyzed with artificial intelligence to detect early-stage cancer.
-
Infographic – We Stand with Ukraine
We stand with Ukraine.
-
Clinical Trial Set for AI-Driven Lung Fibrosis Drug
A clinical trial is set to begin testing the safety and chemical activity of a drug candidate for lung fibrosis, discovered and refined with artificial intelligence.
-
Digital Neuroscience Companies Partner on AR/AI Diagnostics
Two companies creating digital technologies for neurological conditions are collaborating on augmented reality and artificial intelligence in diagnostics.
-
NIH Small Biz Grant Supports Uterine Health Diagnostic
A women’s health diagnostics developer is receiving funds for a non-invasive test analyzing menstrual fluids to detect the uterine disorder endometriosis.
-
Precision Meds Continue Gaining FDA Approvals
Food and Drug Administration approved 17 new medications in 2021 addressing genetic targets, according to data from a precision medicine advocacy group.
-
New Industry, Academic Studies Arrive at Space Station
Several experiments from companies and academic labs arrived today at the International Space Station to test effects of microgravity and other conditions.
-
Infographic – Simulated Clinical Trials Gain Traction
In 2021, 15 simulated or in silico trials, as they’re called, were underway, a rapid jump in this technique from the two trials reported 2018.
-
Precise Stimulation Shown to Reduce Parkinson Symptoms
Light-activated stimulation of a precise set of nerve cells in the brainstem is shown to improve motor abilities in lab mice induced with Parkinson’s disease.
-
Whole Genome Sequencing Shown to Detect Neuro Disorders
An analysis of genetic database records indicates a class of neurological diseases can be detected by sequencing of a person’s entire genome.